期刊文献+

HPV L1壳蛋白在宫颈病变中的表达及与HR-HPV DNA的关系 被引量:8

A Study on the Expression of HPV L1 Capsid Protein in Cervical Lesions and the Relation to HR-HPV DNA
下载PDF
导出
摘要 目的研究人乳头瘤病毒(HPV)L1壳蛋白在宫颈病变中的表达及与高危型人乳头瘤病毒(HR-HPV)DNA的关系,为宫颈病变的早期诊断提供预测指标,为HPV疫苗的研制提供理论依据。方法采用免疫细胞化学方法和第二代杂交捕获法(HC-Ⅱ),分别检测272例女性HPV L1壳蛋白的表达和高危型HPV(HR-HPV)病毒载量,组织活检复查宫颈病变情况。结果 HR-HPV DNA感染者中,随着宫颈病变级别(CINⅠ及以上)的升高,HPV L1壳蛋白阳性表达率增高(x^2=35.176,P<0.001),HPV L1壳蛋白诊断CINⅡ及以上的灵敏度为89.77%,特异度为45.12%;按年龄分层后,HPV L1壳蛋白表达与宫颈病变的OR均小于1;小于35岁研究对象中,病毒载量与HPV L1壳蛋白阳性表达率之间存在剂量反应关系(x^2=12.915,P<0.001)。结论 HPV L1壳蛋白的缺失与宫颈癌及癌前病变的发生、发展密切相关,年轻女性HPV L1壳蛋白的表达与HPVDNA载量存在剂量反应关系。 Objective The paper was to study the expression of HPV L1 capsid protein in cervical lesions and the relation to HR-HPV DNA,to provide a new biomarker for early diagnosis of cervical lesions,and to provide evidence for manufacture of HPV vaccine.Methods Immunochemical method and Hybrid Capture Ⅱ were used to detect the expression of HPV L1 capsid protein and HR-HPV DNA virus load in 272 women,respectively.Cervical lesions were detected by biopsies.Statistical analysis was carried out with the SPSS program,version 13.0.One-way AVONA and χ2 test were used for hypothesis test,Mantel trend analysis was used to analyze the dose-effect relationship between HR HPV virus load and the expression of HPV L1 capsid protein,and values of P〈0.05 were considered statistically significant.Results The expression of HPV L1 capsid protein decreased with biopsy diagnosis increasing in HR-HPV infected women(χ2=35.176,P〈0.001).The sensitivity of HPV L1 capsid protein diagnosing CIN Ⅱ and above in HR-HPV infected women was 89.77%,and the specificity was 45.12%.Stratified analysis showed the value of OR between the expression of HPV L1 capsid protein and cervical lesions was less than 1.Mantel trend analysis showed dose-response relationship between HR-HPV virus load and the expression of HPV L1 capsid protein in women less than 35 years.Conclusion The absence of HPV L1 capsid protein is closely related to the occurrence and development of cervical lesions;there are dose-relationship between HR-HPV virus load and the expression of HPV L1 capsid protein in young women.
出处 《国际检验医学杂志》 CAS 2010年第6期554-556,共3页 International Journal of Laboratory Medicine
关键词 人乳头瘤病毒16 DNA 宫颈肿瘤 宫颈上皮内瘤样病变 核酸杂交 human papillomavirus 16 DNA uterine cervical neoplasms cervical intraepithelial neoplasia nucleic acid hybridization
  • 相关文献

参考文献7

  • 1Queiroz C,Silva TC,Alves VAF,et al.P16(INK4A)expression as a potential prognostic marker in cervical preneoplastic and neoplastic lesions[J].Pathol Res Pract,2006,202(2):77-83.
  • 2Melsheimer P,Kaul S,Dobeck S,et al.Immunocytochemical detection of HPV high-risk type L1 capsid proteins in LSIL and HSIL as compared with detection of HPV L1 DNA[J].Acta Cytol,2003,47(2):124-128.
  • 3Hagensee ME,Koutsky LA,Lee SK,et al.Detection of cervical antibodies to human papillomavirus type 16 (HPV-16)capsid antigens in relation to detection of hpv16 DNA and cervical lesions[J].J Infec Dis,2000,18(40):1234-1239.
  • 4Lowy DR,Schiller JT.Prophylactic human papillomavirus vaccines[J].J Clin Invest,2006,116(5):1167-1173.
  • 5von Knebel Doeberitz M,Bauknecht T,Bartsch D,et al.Influence of chromosomal intergration on glucocorticoidregulated transcription of growth-stimulating papillomavirus genes E6 and E7 in cervical carcinoma cells[J].Proc Natl Acad Sci USA,1991,88(4):1411-1415.
  • 6Rauber D,Mehlhorn G,Fasching PA,et al.Prognostic significance of the detection of human papilloma virus L1 protein in smears of mild to moderate cervical intraepithelial lesions[J].Eur J Obstet Gynecol Reprod Biol,2008,140(2):258-263.
  • 7Masumoto N,Fujii T,Ishikawa M,et al.Dominant human papillomavirus 16 infection in cervical neoplasia in young Japanese women;study of 881 outpatients[J].Eur J Obstet Gynecol RB,2004,94(2):509-514.

同被引文献105

  • 1黄庆,府伟灵,周玉,张雪,黄君富,陈斌.基因芯片对人乳头瘤病毒的快速检测和分型[J].中华医院感染学杂志,2005,15(4):476-478. 被引量:50
  • 2谭晓燕,赵静,刘小宁,吴丽容,冯碧清,黄春英.珠海市正常人群妇女宫颈人乳头状瘤病毒感染情况分析[J].中国妇幼保健,2005,20(14):1726-1727. 被引量:22
  • 3陶萍萍,卞美璐,李敏,刘军.HPV多重感染与宫颈病变关系探讨[J].中国妇产科临床杂志,2006,7(2):94-96. 被引量:112
  • 4黄进波,叶珊.基因芯片检测人乳头瘤病毒23种亚型的应用评价[J].中国皮肤性病学杂志,2007,21(2):78-81. 被引量:10
  • 5Thrall MJ, Pambuccian SE, Stelow EB, et al. Impact of the more restrictive definition of atypical squamous ceils introduced by the 2001 Bethesda System on the sensitivity and specificity of the Papanicolaou test. Cancer Cytopathology, 2008, 114 (3) : 171-179.
  • 6Wright TC Jr, Massad KS, Dunton CJ, et al. 2006 consensus guidelines for the management of women with abnormal cervical cancer screening tests. J Low Genit Tract Dis, 2007, 11 (4) :201-222.
  • 7Jordan J, Arbyn M, Martin-Hirsch P, et al. European guidelines for quality assurance in cervical cancer screening: recommendations for clinical management of abnormal cervical cytology, partl. Cytopathology, 2008, 19(6) :342-354.
  • 8Zur Hause H. Papillomaviruses in the causation of human canca brief historical account. Virology, 2009, 384 (2) :260-265.
  • 9Doeberitz MK, Vinokurova S. Host factors in HPV-related carcinogenesis : cellular mechanisms controlling HPV infections. Arch Med Res, 2009, 40(6) :435-442.
  • 10Khan MJ, Castle PE,Lorincz AT, et al. The evelated 10-year risk of cervical precaocer and cancer in women with human papillomavirus (HPV) type 16 or lgand the possible utility of type-specific HPV test in clinical practice. J Natl Cancer Inst, 2005, 97(14) :1072-1079.

引证文献8

二级引证文献51

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部